Prevalence of depression and associated risk factors among persons with type-2 diabetes mellitus without a prior psychiatric history: a cross-sectional study in clinical settings in urban Nepal by Niraula, Kiran et al.
RESEARCH ARTICLE Open Access
Prevalence of depression and associated risk
factors among persons with type-2 diabetes
mellitus without a prior psychiatric history: a
cross-sectional study in clinical settings in
urban Nepal
Kiran Niraula1,2*, Brandon A Kohrt3,4, Meerjady Sabrina Flora5, Narbada Thapa6, Shirin Jahan Mumu7, Rahul Pathak8,
Babill Stray-Pedersen9, Pukar Ghimire10, Bhawana Regmi11, Elizabeth K MacFarlane4 and Roshni Shrestha12
Abstract
Background: Diabetes is a growing health problem in South Asia. Despite an increasing number of studies
exploring causal pathways between diabetes and depression in high-income countries (HIC), the pathway
between the two disorders has received limited attention in low and middle-income countries (LMIC). The aim of
this study is to investigate the potential pathway of diabetes contributing to depression, to assess the prevalence
of depression, and to evaluate the association of depression severity with diabetes severity. This study uses a
clinical sample of persons living with diabetes sequelae without a prior psychiatric history in urban Nepal.
Methods: A cross-sectional study was conducted among 385 persons living with type-2 diabetes attending
tertiary centers in Kathmandu, Nepal. Patients with at least three months of diagnosed diabetes and no prior
depression diagnosis or family history of depression were recruited randomly using serial selection from
outpatient medicine and endocrine departments. Blood pressure, anthropometrics (height, weight, waist and
hip circumference) and glycated hemoglobin (HbA1c) were measured at the time of interview. Depression was
measured using the validated Nepali version of the Beck Depression Inventory (BDI-Ia).
Results: The proportion of respondents with depression was 40.3%. Using multivariable analyses, a 1-unit (%)
increase in HbA1c was associated with a 2-point increase in BDI score. Erectile dysfunction was associated with a
5-point increase in BDI-Ia. A 10mmHg increase in blood pressure (both systolic and diastolic) was associated with
a 1.4-point increase in BDI-Ia. Other associated variables included waist-hip-ratio (9-point BDI-Ia increase), at least
one diabetic complication (1-point BDI-Ia increase), treatment non-adherence (1-point BDI-Ia increase), insulin use
(2-point BDI-Ia increase), living in a nuclear family (2-point BDI-Ia increase), and lack of family history of diabetes
(1-point BDI-Ia increase). Higher monthly income was associated with increased depression severity (3-point
BDI-Ia increase per 100,000 rupees, equivalent US$1000).
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Conclusions: Depression is associated with indicators of more severe diabetes disease status in Nepal. The
association of depression with diabetes severity and sequelae provide initial support for a causal pathway from
diabetes to depression. Integration of mental health services in primary care will be important to combat
development of depression among persons living with diabetes.
Keywords: Diabetes, Depression, Glycated hemoglobin, Global mental health, Beck Depression Inventory,
Developing country, South Asia, Nepal
Background
Diabetes mellitus is a growing public health concern in
Asia, where more than 110 million people are living with
diabetes, and more than 1.0 million people die annually in
the region from the disorder [1]. In South Asia, greater
population-level affluence is associated with an increase in
health compromising behaviors related to chronic diseases
such as cardiovascular disease, cancer, and diabetes [2].
With prevalence greater than 6% and growing rapidly in
South Asia, the expected prevalence increase in India is
171% from 2007 to 2025 [1].
Worldwide, the prevalence of mood and anxiety disorders
is higher among persons living with diabetes compared to
those without diabetes [3-5]. In a meta-analysis of 42 pub-
lished studies comprised of 21,351 adults, the prevalence of
major depression in people with diabetes was 11% and the
prevalence of clinically relevant depression was 31% ([4], c.f.
[6]). The bidirectional relationship of diabetes with depres-
sion is presented by many studies [7-9]. Co-morbid depres-
sion among persons living with diabetes is associated with
poor markers of diabetes control, such as glycemic control
[10], retinopathy, nephropathy, neuropathy, micro-vascular
complications and sexual dysfunction [11]. Depression is
more prevalent among females with diabetes than males
with diabetes [12], patients with type 2 versus type 1 dia-
betes [13] and those who are treated with insulin [14]. De-
pression in patients with both type 1 and type 2 diabetes is
associated with psychosocial stressors of chronic medical
condition [15]. An increased risk of type 2 diabetes in indi-
viduals with depression is likely due to increased counter-
regulatory hormone release and action, alterations in glucose
transport function, and increased immune-inflammatory ac-
tivation [16]. Patients with diabetes have lower quality of life
ratings, with the greatest quality reduction when depression
and diabetes are comorbid [17,18].
The association of depression and diabetes has been re-
ported in South Asia. In India, a hospital-based study sug-
gested a prevalence of depression ranging from 8.5% to
32.5% depending upon the scales used [19]. In India, de-
pression among persons living with diabetes has been as-
sociated with age, obesity, increased pill burden and
complications of neuropathy and retinopathy [20], as well
as somatic symptoms among females, and genital symp-
toms among males [19]. In Pakistan, history of gestational
diabetes mellitus, nuclear family, obesity, marital status,
history of smoking and history of high blood pressure
were risk factors for depression among type 2 diabetes
mellitus patients [21]. In Bangladesh, prevalence rates of
depression among persons living with diabetes ranges
from 28-34% [12,22,23] with differences by gender, e.g.
22% prevalence in males and 35% prevalence in females
[12]. Risk factors in Bangladesh include being unmarried,
insulin use, and poor glycemic control.
In Nepal, no studies to date have investigated the preva-
lence of depression and diabetes comorbidity. The preva-
lence of diabetes in Nepal is estimated to be 436,000 (2%)
in 2000 and it is projected to affect 1,328,000 persons (10%
prevalence) in 2030 [24]. However, in another study of a
semi-urban sample, the current prevalence of type 2 dia-
betes mellitus in Nepal was identified as 9.5% with impaired
fasting glucose having a prevalence of 19.2%. Prevalence
rates were highest among middle-aged and older men [25].
Other studies in Nepal have suggested prevalence rates of
15% among persons 20–39 years old and 19% among 40
years and older [26]. In Bir Hospital, the central govern-
ment hospital in Kathmandu, diabetes was reported to be
the seventh most common reason for medical admissions
with 2.5% prevalence [27], whereas in Tribhuvan University
Teaching Hospital in Kathmandu, diabetes comprised 9.5%
of total medical admissions per year [28].
The aim of this cross-sectional study was to identify the
prevalence of depression among type 2 diabetes patients
not previously diagnosed with a mood disorder, as well as
to identify risk factors for depression among persons with
diabetes. We were specifically interested in the causal
pathway from diabetes to depression. Therefore exclusion
criteria were designed to minimize the number of partici-
pants for whom depression may have preceded diabetes.
The study focuses on clinical populations with the goal of
providing prevalence estimates and risk factor associations
to guide clinical prevention and management of mood




Nepal is among the world’s poorest countries [29] with a
GDP of $260 per year, which is unequally divided. Nepal
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recently endured the People’s War fought between the
Communist Party of Nepal (Maoists) and government
security forces from 1996 through 2006. Thapa and
Sijapati [30] state that the economy of Nepal has favored
the urban, the rural rich, and elites. Moreover, economic
and political power is centralized in the capital, with
minor representation from rural regions. In addition,
Nepal tops the gender inequality index in South Asia, with
a greater workload burden for women than men, lower lit-
eracy rates, earlier average mortality, and a myriad of dis-
criminatory laws [31]. Ethnic inequality, institutionalized
through the Hindu caste system, is represented by the lack
of ethnic diversity in government positions. In 2001, 98%
of people passing civil service examination were from
Hindu hill groups, even though they constitute 29% of the
population [30].
Community-based epidemiological studies in Nepal
suggest a prevalence of depression ranging from 28% to
41% [32,33], with rates considerably greater among
women, members of lower caste (Dalit) groups [34,35],
the elderly and medically ill. While these high rates are
influenced by the recent history of political violence, a
study examining depression pre and post-war found no
change in rates due to conflict related violence. This
suggests that endemic poverty, lack of healthcare, and
discrimination against women and persons from lower
castes are chronic risk factors for poor mental health
predating the conflict [33]. One study examined the as-
sociation of psychosomatic complaints among persons
with depression, finding that two-thirds of psycho-
somatic complaints were either medical comorbidities or
medical conditions that cause both somatic complaints
and psychiatric problems. Diabetes was a common co-
morbidity with depression [36].
Participants
A cross-sectional study was conducted in three urban
medical centers in Nepal’s capital city Kathmandu: (1)
medical university (Tribhuvan University Teaching Hos-
pital), (2) private medical college (Nepal Medical College)
and (3) private hospital (Om Hospital and Research
Center). The diversity of sites created the ability to ob-
tain a range of participants across socioeconomic levels
from 75 districts of Nepal.
Inclusion and exclusion criteria
Every third patient with type 2 diabetes from the endo-
crine and medicine outpatient departments in all three
centers was recruited. Patients were required to have a
diagnosis of at least three months duration. Patients with
chronic medical illnesses before detection of diabetes,
pregnant women, and patients with a psychiatric history
were excluded. Criteria for psychiatric history included
history of taking anti-depressant medication, any prior
diagnosis of depression, and patients with a family history
of depression or mental illness. Patients with a family his-
tory of depression or other mental illness were excluded
because the study examined depression as a secondary
condition to diabetes. To investigate risk factors for
current depression symptoms among anti-depressant
naïve patients, patients currently taking anti-depressant
medication were excluded because medication may reduce
depression symptom burden, thus reducing the associ-
ation of risk factors with current symptoms.
Ethical approval
The study was conducted from June 2011 through June
2012 and participant recruitment was active from No-
vember 2011 through April 2012. Ethical approval was
obtained from the Nepal Health Research Council and
the Bangladesh Diabetes Association Ethical Review
Committee. Permission was obtained from hospital rep-
resentatives to allow recruitment at their respective facil-
ities. Participants were provided with informed consent
forms. If level of literacy was a concern, the consent
form was read aloud to the participants.
Instruments
In previous studies, the Beck Depression Inventory
(BDI) has been used as a tool to accurately assess de-
pressive symptoms among patients with type 2 diabetes
mellitus [37,38]. The Nepali version of Beck Depression
Inventory (BDI-Ia) was used for assessing depression
among persons living with diabetes. The BDI-Ia was vali-
dated for use with Nepali speakers with sensitivity 0.73
and specificity of 0.91 at a cut-off score of 20 indicating
clinical levels of symptoms severity [35,39,40]. Test re-
test reliability was 0.90 and internal reliability was 0.92.
A semi-structured, pre-tested questionnaire was ad-
ministered by the interviewers to collect information on
socio-demographic characteristics, disease variables, and
behavioral characteristics. The questionnaire was pre-
pared in English and translated into Nepali language and
was reviewed by Nepali psychiatrists, endocrinologists,
epidemiologists, and biostatisticians. Pre-testing of the ques-
tionnaire was performed to gather information about under-
standability, time consumed by each question, consistency
among related variables and acceptability. After reviewing
the outcome of pre-testing, changes were incorporated ac-
cordingly. Medical interns and nurses in the outpatient de-
partments were given a short course on data collection
using the instruments, including anthropometric measure-
ments (BMI, WHR), clinical parameters (blood pressure),
and use of the Nepali BDI-Ia. Height, weight, waist circum-
ference and hip circumference were measured using stand-
ard clinical protocols.
After the interviews, patients were then taken to the
hospital laboratory for blood draws for analysis of HbA1c
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using 2ml of venous blood. The local supervisor, a profes-
sor of epidemiology, reviewed all procedures and notation
at the end of each day.
Statistical analyses
Sample size was estimated using the prevalence of de-
pression among persons with type 2 diabetes from a re-
cent study conducted in Bangladesh at a tertiary care
center [22]. Using an estimated prevalence of 35%, 95%
confidence intervals, and absolute precision of 5%, a
sample size of 348 was determined. This study recruited
385 patients.
Statistical comparisons of socio-demographic variables
between male and female patients were conducted using
chi-squared tests and t-tests for categorical and continu-
ous variables respectively. Odds ratios (OR) with 95%
confidence interval (CI) were calculated for categorical
comparisons. All tests were two-tailed and with p < 0.05
considered statistically significant. Bivariate and multi-
variable statistical analyses were conducted using linear
regression. Regression coefficients (β) and 95% CI are
presented for multivariable and bivariate linear regres-
sions with total BDI-Ia score as the dependent outcome.
Multiple linear regressions were performed to adjust for
potential confounding factors.
The final multivariable model included sex, age, religion,
ethnicity/caste, marital status, years of education, monthly
income, family type, number of family members, parental
history of DM, family history of HTN, personal history of
HTN, smoking, alcohol use, treatment non-adherence,
DM complications, erectile dysfunction, systolic blood
pressure, diastolic blood pressure, waist-hip-ratio, and gly-
cated hemoglobin. These variables were included in the
model because of a known history of association with de-
pression in Nepal or other study populations. Body-mass-
index was not included in the multivariable model because
it was not statistically significant in bivariate analysis with
depression and because of high collinearity with waist-
hip-ratio. Although systolic and diastolic blood pressures
are collinear, when entered in the same multivariable
model, they both remained significant. Therefore, both
were kept in the model.
Results
Sample characteristics
The sample included 48.3% men and female 51.7% women
(see Tables 1 and 2). The mean ± standard deviation (SD)
for age was 52.0 ± 13.1 years, with males 6 months older
than females, which was not a statistically significant dif-
ference (t = 0.4, df = 383, p = 0.7). The majority of partici-
pants practiced Hinduism (76.6%) and 17.4% practiced
Buddhism. Nearly half (45%) of the participants belonged
to high caste groups (Bahun, Chhetri), more than two-
thirds of participants were married (68.6%), and the
majority lived in nuclear families (79.2%). Among total
participants, 47.5% had a family size less than five mem-
bers. Mean total years of formal education was 5.8 ± 6.7,
with only 52% of participants having any formal educa-
tion and only 20% with high school graduate equivalent
degrees. Illiteracy was greater among female (25.6%)
than males (18.1%). Median monthly income of partici-
pants was Nepali Rupiyaa 10,000, range 0–200,000,
(NRs. 100 = US$1). Median family income was Rs.
30,000, range Rs. 0 – 500,000.
Depression
The mean and standard deviation for total BDI-Ia
score of participants was 19.8 ± 8.0. Male and female
scores were 18.6 ± 7.6 and 20.9 ± 8.1 respectively.
Women had significantly greater BDI-Ia scores com-
pared to men (t = −2.74, df = 383, p < 0.01). The num-
ber of participants with clinical depression (≥20 BDI-Ia
score) was 155 (40.3% of the total sample). Among de-
pressed patients, 48.2% were female and 31.7% were
male. BDI-Ia scores above the cut-off were significantly
associated with sex (χ2 = 10.91, df = 383, p < 0.001).
In bivariate analyses, socio-demographic, economic, an-
thropometric, clinical and biochemical parameters were
significantly associated with BDI-Ia score (See Tables 3
and 4). Female sex associated with a β = 2.2 point in total
BDI-Ia score compared to men (df = 383, p = 0.006).
Participants having family history of diabetes showed a
protective effect of β = −2.7 (95% CI: -4.3,-1.0, df = 383,
p < 0.01) compared to persons without family history of
diabetes (p = 0.02). Patients with at least one diabetic
complication had a 3.6 point higher BDI-Ia score (95%
CI: 2.0, 5.2, df = 383, p < 0.001) and men with erectile dys-
function had greater BDI-Ia scores (β: 8.9; 95% CI: 4.4,
13.4, df = 185, p < 0.001). As the duration of diagnosis of
diabetes increased BDI-Ia score decreased (β: -0.1; 95%
CI: -0.3,-0.01, df = 383, p = 0.03), i.e. persons who were
further along in the disease course, patients reported
fewer depression symptoms. Other significant charac-
teristics were systolic BP (β: 0.3; 95% CI: 0.3, 0.4, df =
383, p < 0.001), diastolic BP (β: 0.4; 95% CI: 0.4, 0.5,
df = 383, p < 0.001), and WHR (β: 18.5; 95% CI: 7.7,
29.4, df = 383, p < 0.001). BMI (β: -0.01; 95% CI: -0.3,-
0.01, df = 383, p = 0.90) was not significant in bivariate
comparisons.
In the multivariable regression, clinical and biochemical
parameters as well as anthropometrics were significantly
associated with depression symptom severity. An increase
of 1 unit (%) HbA1c was associated with a BDI-Ia increase
of 2.08 (See Table 5). An increase of 10mmHg in systolic
and diastolic blood pressure was associated with an in-
crease of 1.3 and 1.4 of BDI-Ia scores, respectively. An in-
crease of 0.1 in waist-hip-ratio was associated with a 1
point increase in BDI-Ia score. Any diabetic complication
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was associated with a BDI-Ia score increase of 1.2,
whereas erectile dysfunction was associated with a 4.74
BDI-Ia score increase. Regarding treatment parameters,
insulin use compared to oral or other treatments was as-
sociated with a 1.74 BDI-Ia score increase, and adherence
was associated with a 1.05 BDI-Ia score decrease. Afflu-
ence was associated with greater depression severity. An
increase of NRs. 100,000 (US$1,000) per month in per-
sonal income predicted an increase of 3 points on total
BDI-Ia score. Other significant parameters included
known family history of hypertension (β = −1.5, df = 362,
p = .01) and living in a nuclear family (β = 1.6, df = 362,
p = .03) as opposed to joint-extended family. Given the
greater depression severity among persons early in the
Table 1 Categorical demographics
Variables Total Male Female Sex difference P value
No. (%) No. (%) No. (%) OR (95% CI)
Sex
Male 186 (48.3) - - - -
Female 199 (51.7) - -
Religion
All others 90 (23.4) 50 (13.0) 40 (10.4) Ref.
Hindu 295 (76.6) 136 (35.3) 159 (41.3) 1.46 (0.91,2.35) 0.12
Ethnicity
High caste 173 (45.0) 83 (21.60) 90 (23.4) Ref.
Newar 65 (16.9) 27 (7.0) 38 (9.9) 1.29 (0.73,2.31) 0.38
Hilly indigenous (Janajati) 90 (23.4) 54 (14.0) 36 (9.4) 0.62 (0.37,1.03) 0.07
Occupational castes (Dalit) 11 (2.9) 8 (2.1) 3 (0.8) 0.35 (0.09,1.35) 0.13
All others 46 (11.9) 14 (3.6) 32 (8.3) 2.11 (1.05,4.23) 0.04
Marital status
Married 264 (68.6) 138 (35.8) 126 (32.7) Ref.
Others 121 (31.4) 48 (12.5) 73 (19.0) 1.66 (1.07,2.57) 0.02
Residence
Rural 60 (15.6) 22 (5.7) 38 (9.9) Ref.
Urban 242 (62.9) 108 (28.1) 134 (34.8) 0.72 (0.40,1.29) 0.27
Sub-urban 82 (21.3) 56 (14.5) 26 (6.8) 0.27 (0.13,0.54) <0.001
Occupation*
Unemployed 8 (2.1) 2 (0.5) 6 (1.56) Ref.
House wife 125 (32.5) 60 (15.6) 65 (16.9) 0.36 (0.07,1.86) 0.22
Farmer 59 (15.3) 28 (7.3) 31 (8.1) 0.37 (0.07,1.98) 0.25
Service 32 (8.3) 15 (3.9) 17 (4.4) 0.38 (0.07,2.16) 0.27
Retired 86 (22.3) 46 (11.9) 40 (10.4) 0.29 (0.01,1.52) 0.14
Laborers 14 (3.6) 8 (2.1) 6 (1.6) 0.25 (0.04,1.70) 0.16
Business 44 (11.4) 20 (5.2) 24 (6.2) 0.40 (0.07,2.20) 0.29
All others 14 (3.6) 7 (1.9) 7 (1.8) 0.33 (0.05,2.26) 0.26
Education
No formal 182 (47.3) 85 (22.07) 97 (25.20) Ref.
Below primary 38 (9.9) 15 (3.9) 23 (6.0) 1.34 (0.66,2.74) 0.42
Primary/secondary 57 (14.8) 27 (7.0) 30 (7.8) 0.974 (0.54,1.77) 0.93
School leaving certificate 108 (28.1) 59 (15.3) 49 (12.7) 0.73 (0.45,1.18) 0.19
Family type
Nuclear 305 (79.2) 148 (38.4) 157 (40.8) Ref.
Joint 80 (20.8) 38 (9.9) 42 (10.9) 1.04 (0.64,1.71) 0.87
*Two individuals were students. Results did not include these two individuals in occupation analysis because of small sample and unstable confidence interval.
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diagnosis and treatment process, a sensitivity analysis
of diagnoses within the past 3 years was conducted.
However, no additional risk factors were identified.
Discussion
This was a cross-sectional study conducted in three clin-
ical settings of urban Nepal. The aim of the study was to
find the prevalence of depression among persons living
with diabetes and to identify probable risk factors. Pa-
tients who were diagnosed with diabetes at least three
months prior to the study were included. Patients with
other chronic medical illnesses before detection of dia-
betes, pregnant women with diabetes, people having psy-
chiatric problems before diagnosis of diabetes, people
who were taking anti-depressants and people who had a
family history of depression were excluded. The goal of
these criteria was to minimize the likelihood of depres-
sion as a pre-existing condition and instead identity de-
pression that occurred secondary to diabetes.
In the present study, the proportion of participants
with BDI-Ia scores above the clinically validated cutoff
in Nepal (BDI ≥ 20) was 40.3%. This rate is comparable
to prevalence of depression (36.6%), as reported in a
worldwide meta-analysis of studies among persons with
diabetes in clinical settings [41]. The rate is higher than
that observed in the United States, where prevalence of
depression among persons with diabetes ranges from
2%-28% [14.] Our observed rate is comparable to
Mexican-born Americans in the Texas who display a
40% prevalence rate [42] and comparable to a German
study with a depression prevalence among persons with
diabetes of 41.9% also using the BDI [43]. The observed
rate in this study was at the upper range of other studies
conducted in South Asia. Hospital-based studies from
India showed prevalence ranging from 8.5%-32.5% [19].
Asghar et al. did a community based study in Bangladesh,
which showed 27.9% depression among type 2 diabetes
patients [12]. A tertiary hospital based study conducted
in Bangladesh showed 34.8% depression in persons living
with diabetes [22].
Risk indicators for depression in patients with
type 2 diabetes
As expected, complications of diabetes were significantly
associated with depression. This has been observed
across most studies of depression and diabetes in both
high [44,45] and low-income settings including South
Asia [21,22]. Erectile dysfunction was one of the stron-
gest predictors of depression, which is consistent with
De Groot et al. [11] and Lustman et al., [10]. In this
study family history of diabetes was associated with
lower depressive symptoms than those who had no fam-
ily history. While the study does not have quantitative or
qualitative data to illuminate the association, it is specu-
lated that family history may reduce fear and anxiety
related to the disorder as well as normalize the experi-
ence, resulting in lower psychological distress. As with
other studies, insulin use predicted greater depression,
with insulin likely a proxy for greater disease severity
[4,14,22,41,46-49]. The study showed non-adherence to at
least one aspect of the diabetes management plan (life
style, diet, medication) was strongly associated (p < 0.001)
with depression, consistent with studies in high-income
countries [3,17,50,51]. Studies showed not checking blood
sugar [3], lack of regular exercise [45], lack of medical
vigilance, and lack of dietary modification [49] were
associated with depression. Time since diabetes diag-
nosis was inversely associated with depression severity,
suggesting that the early experience of the disease is
the period of greatest psychological distress and adjust-
ments in lifestyle. High blood pressure, either systolic
or diastolic, was associated with greater depression se-
verity, similar to other findings [21,22]. Glycemic sta-
tus (glycated hemoglobin) was consistently associated
with depression in almost all studies done so far in
research related to depression among type 2 diabetes
[10,22,47,52-55]. HbA1c was strongly associated with
depression in this study as well, which is also a likely
proxy for disease severity.
A number of risk factors associated with depression in
Nepal were not significantly associated with depression
Table 2 Continuous demographics






Age (years) 23-100 52.0 ± 13.1 52.2 ± 12.6 51.7 ± 13.5 0.40 −2.10, 3.15 0.69
Education (years) 0-19 5.8 ± 6.7 6.3 ± 6.9 5.4 ± 6.5 1.29 −0.46, 2.22 0.20
No of members in family 1-20 5.0 ± 3.0 5.1 ± 3.1 4.8 ± 2.8 1.21 −0.23, 0.96 0.23
Monthly income (thousand rupees) 0-200 17.9 ± 37.0 18.7 ± 39.9 17.2 ±34.2 0.40 −59.20, 89.39 0.69
Monthly family income (thousand rupees) 0-500 50.7 ± 68.2 43.9 ±5.6 57.0 ± 77.3 −1.89 −26.73, 51.69 0.06
Monthly family expenditure (thousand rupees) 0-130 28.7 ± 25.9 26.7 ± 24.1 30.6 ± 27.3 −1.51 −91.47, 12.09 0.13
Monthly diabetes related health care cost
(thousand rupees)
0-35 2.2 ± 4.3 2.1 ± 4.2 2.3 ± 4.5 −0.48 −1.08, 0.66 0.63
Note: 1000 Nepali Rupees is equivalent to approximately 10 US dollars.
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Table 3 Bivariate regression of categorical variables with depression symptom severity (total BDI-Ia score)
Characteristics Total samples
Variables Categories Mean (SD) Beta (95% CI) P Value
Sex Male 18.6 ± 7.6 Ref. <0.01
Female 20.9 ± 8.1 2.2 (0.6, 3.8)
Religion All others 21.3 ± 8.7 Ref. 0.03
Hindu 19.3 ± 7.7 −2.1 (−4.0,-0.2)
Ethnicity High caste 19.3 ± 7.3 Ref.
Newar 19.6 ± 8.4 −0.7 (−3.3,1.9) 0.62
Hilly indigenous (Janajati) 20.5 ± 8.6 −0.4(−3.4,2.6) 0.80
Occupational castes (Dalit) 21.1 ± 10.7 0.5 (−2.4,3.3) 0.74
Others 20.0 ± 7.7 1.1 (−4.2,6.4) 0.68
Marital status Married 20.6 ± 8.2 Ref.
All others 19.41 ± 7.9 −1.2 (−2.9,0.5) 0.17
Residence Rural 20.2 ± 7.8 Ref.
Urban 20.3 ± 8.3 2.3 (−0.4,4.9) 0.09
Sub-urban 17.9 ± 6.7 2.4 (0.4,4.5) 0.02
Occupation Unemployed 20.4 ± 17.9 Ref.
House wife 19.6 ± 8.0 2.9 (−4.1,9.8) 0.42
Farmer 21.7 ± 6.7 2.1 (−2.4,6.5) 0.36
Service 19.1 ± 9.1 4.2 (−0.5,8.9) 0.08
Retired 19.3 ± 7.3 1.6 (−3.4,6.6) 0.53
Student 20.0 ± 5.7 1.8 (−2.8,6.3) 0.44
Laborers 18.5 ± 10.0 2.5 (−9.4,14.4) 0.68
Business 20.2 ± 7.0 1.0 (−4.9,6.9) 0.74
All others 17.5 ± 6.5 2.7 (−2.1,7.6) 0.27
Education No formal 20.7 ± 7.7 Ref.
Formal but below primary 20.2 ± 7.1 2.7 (0.8,4.6) <0.01
Primary/secondary 20.2 ± 7.7 2.3 (−0.6,5.2) 0.12
SCL + (class 10 passed) 17.9 ± 8.6 2.2 (−0.3,4.8) 0.09
Family type Nuclear 19.8 ± 7.5 Ref.
Joint 19.9 ± 9.6 0.1 (−1.9,2.1) 0.91
Parental history of DM No 20.7 ± 7.9 ref
Yes 18.0 ± 7.8 −2.7 (−4.3,-1.0) <0.01
Treatment modality Oral 19.5 ± 7.7 Ref.
Any insulin 21.5 ± 8.4 2.8 (0.5,5.2) 0.02
All others 16.7 ± 6.9 4.77 (2.3,7.3) <0.001
Non adherence No 18.2 ± 7.2 Ref.
Yes 22.6 ± 8.5 4.4 (2.8, 6.0) <0.001
Frequency of non adherence ≤once a week 19.8 ± 8.9 Ref.
>one a week 24.8 ± 7.5 5.0 (2.3,7.8) <0.001
Any diabetic complication No 17.9 ± 7.0 Ref.
yes 21.4 ± 8.4 3.6 (2.0,5.2) <0.001
Erectile dysfunction No 19.5 ± 7.9 Ref.
Yes 28.4 ± 4.8 8.9 (4.4,13.4) <0.001
Smoking Never 19.6 ± 7.3 Ref.
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among this clinical population with diabetes. For ex-
ample, gender was not a significant predictor of depres-
sion among persons with diabetes in the multivariable
regression model. This contrasts with community stud-
ies of depression that show a consistently greater preva-
lence among Nepalese women compared to men [32,33].
In a study of women with diabetes in India, Weaver and
Hadley [56] found that not fulfilling gender-specific so-
cial roles predicted greater levels of depression. In this
sample, there may be no gender differences between
men and women because diabetes impairs gender-role
performance for both sexes, as suggested by greater de-
pression among men living with diabetes with erectile
dysfunction. Diabetes may have comparable functional
consequences for both genders, whereas women in
Nepal are more vulnerable socially even in the absence
of physical disease [34].
Age is a strong predictor of depression in the general
community in Nepal [32,33,35]. However, it was not a
significant predictor in this Nepali clinical population
with diabetes. Age has shown an inconsistent relation-
ship with depression and in people with diabetes with
depression in a number of studies: Goldney et al. also
did not find an association of age with depression among
persons living with diabetes [17]. Ravel et al. did found
depression to be strongly associated with age above 54
years [20].
In this study, caste and ethnicity were not significantly
associated with depression. However, community-based
samples in rural Nepal show a greater preponderance of
depression among low-caste Dalit groups [3,35,57-59].
In other countries, ethnic minorities with diabetes dis-
play more depression than majority groups [44,48,60,61].
Marital status also was not significant, despite being a
predictor in rural Nepal and in studies of persons living
with diabetes in other countries (Pakistan) [21]. This
study showed participants from urban area were more
depressed (p < 0.001) which is not consistent with other
studies where rural population was more depressed
[20,51]. It is important to note that the prevalence of de-
pression in this sample of persons living with diabetes
(40%) is comparable to rates of depression observed
among other risk groups in Nepal such as low caste
Dalit groups (BDI-Ia-based depression prevalence, 50%)
[35], populations with high political violence exposure
including both adult civilians (Dang district, BDI-Ia-
based depression prevalence, 43%) [32] and child sol-
diers (depression prevalence, 53%) [59], and populations
with high rates of structural violence including poverty,
lack of education, lack of health care, and high rates of
Table 3 Bivariate regression of categorical variables with depression symptom severity (total BDI-Ia score) (Continued)
Past 19.0 ± 8.5 −1.2 (−3.2,0.7) 0.22
Current 20.9 ± 8.6 −1.7 (−4.1,0.3) 0.10
Alcohol use Never 19.6 ± 7.7 Ref.
Past 20.3 ± 7.5 −0.1 (−2.1,1.9) 0.93
Current 19.7 ± 8.9 0.6 (−1.7,2.8) 0.61
History HTN No 18.8 ± 7.68 Ref.
Yes 20.8 ± 8.15 2.0 (0.4,3.6) 0.01
HTN medication No 16.2 ± 5.4 ref
Yes 20.9 ± 8.1 4.7 (1.0,8.5) 0.01
Family history of HTN No 20.6 ± 8.2 Ref.
Yes 18.3 ± 7.8 −1.8 (−3.6,-0.1) 0.03
Abbreviations: BDI, Beck Depression Inventory; SLC+, School Leaving Certificate (high school graduation equivalent); HTN, hypertension; DM, diabetes mellitus.
Table 4 Bivariate regression of continuous variables with
depression symptom severity (total BDI Score)
Characteristics Beta (95% CI) p-value
Age (years) −0.09 (−0.15, -0.03) <0.01
Education (years) −0.17 (−0.29, -0.05) <0.01
No of members in family −0.02 (−0.29, 0.25) 0.90
Monthly income (thousand rupees) 0.01 (−0.01, 0.03) 0.33
Monthly family income
(thousand rupees)
−0.01 (−0.00, 0.01) 0.85
Monthly family expenditure
(thousand rupees)
−0.01 (−0.04, 0.02) 0.54
Monthly diabetes related health
care cost (thousand rupees)
−0.01 (−0.00,0.01) 0.87
Duration of diagnosis of DM −0.13 (−0.25,-0.01) 0.03
Duration of diagnosis of HTN 0.09 (−0.06,0.24) 0.26
Systolic BP 0.31 (0.27,0.35) <0.001
Diastolic BP 0.42 (0.37,0.48) <0.001
BMI −0.01 (−0.21,0.18) 0.90
WHR 18.5 (7.65,29.44) <0.001
HbA1c 3.16 (2.82, 3.49) <0.001
Abbreviations: BDI, Beck Depression Inventory; HTN, hypertension; DM,
diabetes mellitus; BP, blood pressure; BMI, body mass index; WHR, waist-hip
ratio; HbA1c, glycated hemoglobin.
Note: 1000 Nepali Rupees is equivalent to approximately 10 US dollars.
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gender discrimination (Jumla district, BDI-based depres-
sion prevalence, 41%) [33].
In this study, greater personal income was associated
with greater depression. Although this study showed par-
ticipants with high income were more depressed (p < 0.01)
than their lower income counterparts, Bell et al. [50],
Egede et al. [60], Everson et al. [61] suggests patients
with lower income have more depression. In India,
mixed methods research by Mendenhall and colleagues
[62] suggests that depression is greater among low-
income persons with diabetes, likely influenced by both
greater financial stressors and also by impaired access
to diabetes care. In urban Nepal, wealth may be a proxy
for poorer health overall. Whereas obesity, metabolic
syndrome, and diabetes are greater risks among poor
populations in high income countries, affluence is
Table 5 Multivariable Regression for Depression Symptom Severity (Total BDI-Ia Score)
Variables Predictors for total BDI score
Beta (95% CI) P Value
Intercept −29.92 −38.81, -21.03 <0.001
Sex (female) 0.67 −0.34, 1.67 0.34
Age (years) −0.01 −0.05, 0.03 0.72
Religion (Hindu) −0.81 −2.21, 0.59 0.26
Ethnicity High Caste Hindu Ref.
Newar −0.86 −2.23, 0.50 0.21
Hill indigenous (Janajati) −1.21 −2.75, 0.33 0.12
Occupational castes (Dalit) −0.40 −3.34, 2.54 0.79
All others 0.93 −0.72, 2.58 0.27
Marital status (married) 0.69 −0.45, 1.84 0.24
Years of education −0.06 −0.13, 0.02 0.14
Monthly income (thousand rupees) 0.03 0.01, 0.04 <0.001
Family type (nuclear) 1.60 0.21, 3.00 0.03
Total family members 0.20 −0.00, 0.38 0.05
No known parental history of DM 1.48 0.33, 2.62 0.01
Family history of HTN −0.75 −1.89, 0.38 0.19
History of HTN −0.31 −1.34, 0.72 0.55
Smoking Never Ref.
Past −1.05 −2.40, 0.29 0.12
Current 0.08 −1.32, 1.48 0.91
Alcohol use Never Ref.
Past −0.22 −1.58, 1.14 0.75
Current −0.63 −2.07, 0.81 0.39
Treatment modality for DM Oral Ref.
All insulin 1.74 0.60, 2.88 <0.001
All other −0.81 −2.32, 0.68 0.29
Non-adherence 1.05 0.02, 2.08 0.05
DM complication 1.19 0.18, 2.21 0.02
Erectile dysfunction 4.74 1.94, 7.53 <0.01
BP Systolic (mmHg) 0.13 0.08, 0.17 <0.001
BP Diastolic (mmHg) 0.14 0.08, 0.20 <0.001
WHR 9.12 2.47, 15.77 0.01
HbA1c (%) 2.08 1.76, 2.41 <0.001
R2 = .4, F = 15, df = 369, p < 0.001.
Abbreviations: BDI, Beck Depression Inventory; HTN, hypertension; DM, diabetes mellitus; BP, blood pressure; mmHg, millimeters of mercury; BMI, body mass index;
Kg/m2, kilograms per meter squared; WHR, waist-hip ratio; HbA1c, glycated hemoglobin.
Note: 1000 Nepali Rupee is equivalent to approximately 10 US dollars.
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associated with these poor health outcomes in some
studies in South Asia [2].
However, the rapid economic transitions in India are
demonstrating that high-income groups are able to
mobilize behavioral and medical resources while a grow-
ing burden of chronic health problems falls upon the
middle and lower class, which is the pattern observed in
high-income countries [63,64]. Therefore, wealth may be
a proxy for poor health habits, poor nutrition, limited
exercise, excessive caloric intake, and smoking and
drinking [65] at a specific moment in time in Nepal as
the burden shifts to other groups. Alternatively, the se-
lection criteria may have confounded the association of
wealth and depression, as discussed in the limitations
section below.
The present study did not reveal any association be-
tween behavioral characteristics of tobacco, alcohol, and
other drug use. However, this may be because personal
income was a stronger proxy for a constellation of poor
behaviors in this population. Most other studies have
shown an association of these behaviors with depression
among persons living with diabetes [17,21]. One reason
that smoking may not be associated with poorer outcomes
is the epidemic of respiratory disorders in Kathmandu
given the overwhelming burden of pollution in the city.
The present study showed an association between waist
hip ratio and depression (p = 0.001), which is consistent
with findings from Lustman et al. [10] and Larijani
et al. [43].
Limitations
This study has a number of limitations. The main limita-
tion is the generalizability of findings based on the sam-
ple. The goal was to identify persons with least
likelihood of pre-diabetes depression. While this is help-
ful to consider the pathway from diabetes to depression
and useful to demonstrate the high rate of mental health
problems in persons with no prior history, it does con-
found some of the risk factor associations reported. The
association between higher economic status and depres-
sion may be the result of excluding persons with prior
depression, who are more likely to be low socioeco-
nomic status given the high rates of depression in this
population. Moreover, this study does not provide new
information on the pathway from depression to diabetes.
Further information on this group is needed to explore
how mental health treatment can interrupt the transition
from psychiatric to endocrine morbidity. Ultimately,
studies that include comparisons of community residing
persons with and without diabetes and depression rates
and risk factors is needed to determine pathways and
points of intervention. The strong association of socio-
behavioral risk factors with depression among this group
also highlights the need for models looking at direct and
indirect effects of social marginalization with multiple
mediation through physical health morbidity.
Conclusion
Depression is associated with indicators of more severe
diabetes disease status in Nepal. The associations of de-
pression with diabetic severity and sequel provide initial
support for a causal pathway from diabetes to depression
in Nepal. Integration of mental health services in pri-
mary care will be an important factor in preventing the
development of depression among diabetes patients.
Concealed depression among type-2 diabetes patients
needs to be assessed in every diabetes care setting.
Stepped and collaborative care models for treatment
[66,67] of diabetes and depression should be explored
for treatment options in Nepal and other low-income
countries [23]. Moreover, education about the connec-
tion between physical health and mental health, which
has been used in high-income settings [68], should be
considered for psycho-education programs within this
population. Cognitive Behavior Therapy (CBT) with a
focus on the connection between mind and body has
been adapted for use with Nepali populations [69] and
should be considered for studies with patients suffering
from comorbid depression and diabetes in Nepal. With
lifestyle changes and increasing affluence, the risk of dia-
betes will likely increase on a population level. More re-
search is needed to determine public health measures to
combat greater non-communicable health risks in Nepal.
Mental health, obesity, and metabolic disorders have
common risk factors therefore common solutions should
be pursued rather than separate approaches to preven-
tion of mental and physical health problems [70].
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